# Editorial: Translation of health technology reassessment and its outputs of disinvestment, de-implementation and de-adoption of drugs and medical devices in practice-what have we learned?

**Authors:** Rosmin Esmail, Nora Ibargoyen-Roteta, Maximilian Otte, Iñaki Gutiérrez-Ibarluzea, Roberta Joppi, Hans-Peter Dauben

PMC · DOI: 10.3389/fphar.2025.1700196 · 2025-10-13

## Full-text entities

- **Genes:** TERC (telomerase RNA component) [NCBI Gene 7012] {aka DKCA1, PFBMFT2, SCARNA19, TER, TR, TRC3}
- **Diseases:** Gaucher disease (MESH:D005776), kidney disease (MESH:D007674), H-PD (MESH:D010300), follicular lymphoma (MESH:D008224)
- **Chemicals:** glucose (MESH:D005947), trastuzumab (MESH:D000068878), rituximab (MESH:D000069283), Ala sil (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

---
Source: https://tomesphere.com/paper/PMC12554588